Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma

BACKGROUND: Glioblastoma (GBM) is a universally lethal tumor with frequently overexpressed or mutated epidermal growth factor receptor (EGFR). NADPH quinone oxidoreductase 1 (NQO1) and glutathione-S-transferase Pi 1 (GSTP1) are commonly upregulated in GBM. NQO1 and GSTP1 decrease the formation of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Kecheng, Gu, Xiaoxia, Alvarado, Alvaro G., Du, Yuhong, Luo, Shilin, Ahn, Eun Hee, Kang, Seong Su, Ji, Bing, Liu, Xia, Mao, Hui, Fu, Haian, Kornblum, Harley I., Jin, Lingjing, Li, Hua, Ye, Keqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579906/
https://www.ncbi.nlm.nih.gov/pubmed/33087132
http://dx.doi.org/10.1186/s13045-020-00979-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579906/
https://www.ncbi.nlm.nih.gov/pubmed/33087132
http://dx.doi.org/10.1186/s13045-020-00979-y

Ejemplares similares